TD Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-255
Closed -$39K 324
2020
Q4
$39K Buy
+255
New +$39K 0.01% 143